ArticleFrontiers in oncology2021

Comparison of PD-1 Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma in the Second-Line Setting.

Yi-Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.